Daniel Janney is Director at Krystal Biotech, Inc. (KRYS). They have made 26 open-market trades across 11 companies since 2006, most recently 2026-02-27.
CIK 0001198325
11 open-market purchases totalling $29.7M since 2013, against 15 sales. Across 7 scored buys the stock is up 15.9% at ninety days, and 13.9 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 57% | 43% |
| Avg Move | -5.7% | +8.6% | +15.9% |
| Alpha | -4.0% | +7.4% | +13.9% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 100% | 67% |
| Avg Move | -2.3% | -7.6% | -5.3% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRYS | SELL · 10b5-1 | 2026-02-27 | 2026-03-03 | $275.59 | $3.3M | -7.4% | -2.3% | +11.7% |
| KRYS | SELL | 2026-02-24 | 2026-02-26 | $268.44 | $16.1M | -5.3% | -10.6% | +11.3% |
| KRYS | SELL | 2023-06-08 | 2023-06-09 | $128.43 | $8.3M | -7.1% | -4.5% | -6.1% |
| KRYS | SELL · 10b5-1 | 2023-05-19 | 2023-05-23 | $95.02 | $4.8M | +5.9% | +4.3% | +9.2% |
| KRYS | SELL · 10b5-1 | 2023-05-09 | 2023-05-11 | $90.74 | $1.6M | +31.6% | +42.8% | +31.0% |
| KRYS | SELL · 10b5-1 | 2023-04-19 | 2023-04-21 | $90.32 | $714K | -3.5% | +35.2% | +41.8% |
| ALLK | BUY | 2022-09-21 | 2022-09-23 | $5.02 | $2.4M | +17.5% | +4.0% | +41.4% |
| KRYS | SELL | 2021-12-10 | 2021-12-14 | $70.50 | $7.0M | -0.2% | -14.0% | -13.6% |
| ALLK | SELL | 2021-03-26 | 2021-03-30 | $115.09 | $3.7M | -4.2% | -0.4% | -15.3% |
| ALLK | SELL | 2021-03-22 | 2021-03-24 | $119.70 | $3.1M | +1.2% | -1.2% | -16.5% |
| ALLK | SELL | 2021-03-12 | 2021-03-16 | $124.42 | $2.7M | -4.5% | -10.3% | -24.7% |
| ALLK | SELL | 2021-03-09 | 2021-03-11 | $124.62 | $1.5M | -3.8% | -14.7% | -24.6% |
| KRYS | SELL | 2019-08-29 | 2019-09-03 | $46.46 | $8.2M | +8.4% | -11.8% | +48.1% |
| ALLK | BUY | 2018-07-23 | 2018-07-23 | $18.00 | $4.5M | +14.1% | +8.3% | +22.9% |
| KRYS | BUY | 2017-09-22 | 2017-09-25 | $10.00 | $2.0M | +2.0% | +2.4% | -10.8% |
| ESPR | SELL | 2017-03-21 | 2017-03-23 | $45.79 | $16.0M | -10.9% | -7.4% | +1.1% |
| ESPR | SELL | 2017-03-21 | 2017-03-23 | $45.80 | $16.0M | -10.9% | -7.4% | +1.1% |
| VIVE | BUY | 2017-03-17 | 2017-03-21 | $4.00 | $2.0M | +24.6% | +48.6% | +60.4% |
| VIVMF | BUY | 2016-06-17 | 2016-06-20 | $5.00 | $1.0M | N/A | N/A | N/A |
| NEOT | SELL | 2015-12-15 | 2015-12-17 | $1.44 | $762K | N/A | N/A | N/A |
| VIVMF | BUY | 2015-11-24 | 2015-11-25 | $0.70 | $600K | N/A | N/A | N/A |
| ZSPH | SELL | 2015-06-05 | 2015-06-09 | $57.86 | $10.1M | N/A | N/A | N/A |
| ZSPH | SELL | 2015-06-03 | 2015-06-05 | $57.30 | $6.4M | N/A | N/A | N/A |
| VIVMF | BUY | 2015-05-12 | 2015-05-14 | $0.37 | $1000K | N/A | N/A | N/A |
| ESPR | BUY | 2014-10-21 | 2014-10-21 | $20.00 | $10.0M | -35.3% | -0.8% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| VIVMF |
| 881,954 |
| — |
| ATSI | 11,760,000 | — |
| ZSPH | 2,657,843 | — |
| ANSV | 16,160 | — |
| NEOT | 2,137,763 | — |
| PLCSD | 1,895,788 | — |
| Total | $47.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-03 close. 6 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 6 | 6 | 6 |